Avidity Biosciences, Inc. (RNA)
71.43
+0.17
(+0.24%)
USD |
NASDAQ |
Dec 09, 13:00
Avidity Biosciences Total Liabilities (Quarterly): 247.94M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Novartis AG | 62.54B |
| Eli Lilly & Co. | 91.08B |
| Dyne Therapeutics, Inc. | 175.28M |
| Astria Therapeutics, Inc. | 38.61M |
| Intellia Therapeutics, Inc. | 176.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.134B |
| Shareholders Equity (Quarterly) | 1.886B |
| Debt to Equity Ratio | 0.0265 |
| Current Ratio | 11.57 |
| Net Debt Paydown Yield | -0.13% |